TSX:RVX

Resverlogix Stock Predictions

Healthcare > Biotechnology

Buy RVX

*Your capital is at risk

$0.100

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

RVX.TO Prediction Chart

RVX.TO Predictions History

Latest community submissions for RVX.TO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
JS Pro	Apr 5, 2022	$0.469 +1.96%	$0.460	X	98.04%
mrozario	Apr 5, 2022	Bullish	$0.460	X	—
PumpTheseNumbers Pro	Nov 28, 2019	$1.26 -4.55%	$1.33	X	94.74%
JS Pro	Nov 28, 2019	$1.26 -4.55%	$1.33	X	94.74%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RVX.TO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT RESVERLOGIX CORP.

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a part...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by